Lombard Odier Asset Management (Europe)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,168
| Closed | -$1.25M | – | 285 |
|
|
2022
Q2 | $1.25M | Buy |
+13,168
| New | +$1.25M | 0.06% | 200 |
|
|
2022
Q1 | – | Sell |
-8,353
| Closed | -$1.08M | – | 187 |
|
|
2021
Q4 | $1.08M | Buy |
+8,353
| New | +$1.08M | 0.05% | 148 |
|
|
2021
Q2 | – | Sell |
-4,246
| Closed | -$355K | – | 148 |
|
|
2021
Q1 | $355K | Buy |
+4,246
| New | +$355K | 0.02% | 145 |
|
|
2020
Q2 | – | Sell |
-6,309
| Closed | -$397K | – | 202 |
|
|
2020
Q1 | $397K | Hold |
6,309
| – | – | 0.03% | 181 |
|
|
2019
Q4 | $491K | Hold |
6,309
| – | – | 0.04% | 199 |
|
|
2019
Q3 | $462K | Hold |
6,309
| – | – | 0.04% | 198 |
|
|
2019
Q2 | $389K | Hold |
6,309
| – | – | 0.03% | 229 |
|
|
2019
Q1 | $402K | Hold |
6,309
| – | – | 0.04% | 199 |
|
|
2018
Q4 | $322K | Hold |
6,309
| – | – | 0.03% | 227 |
|
|
2018
Q3 | $366K | Hold |
6,309
| – | – | 0.03% | 239 |
|
|
2018
Q2 | $306K | Hold |
6,309
| – | – | 0.02% | 253 |
|
|
2018
Q1 | $293K | Sell |
6,309
-906
| -13% | -$42.1K | 0.02% | 258 |
|
|
2017
Q4 | $271K | Sell |
7,215
-1,470
| -17% | -$55.2K | 0.02% | 298 |
|
|
2017
Q3 | $316K | Hold |
8,685
| – | – | 0.02% | 291 |
|
|
2017
Q2 | $342K | Hold |
8,685
| – | – | 0.02% | 264 |
|
|
2017
Q1 | $272K | Hold |
8,685
| – | – | 0.02% | 302 |
|
|
2016
Q4 | $271K | Hold |
8,685
| – | – | 0.1% | 270 |
|
|
2016
Q3 | $349K | Buy |
8,685
+591
| +7% | +$23.7K | 0.12% | 228 |
|
|
2016
Q2 | $269K | Buy |
+8,094
| New | +$269K | 0.01% | 311 |
|